ICH Q10 Pharmaceutical Quality System
E133712
ICH Q10 Pharmaceutical Quality System is an international guideline that establishes a comprehensive, lifecycle-based framework for pharmaceutical quality management to ensure consistent product quality and regulatory compliance.
All labels observed (3)
| Label | Occurrences |
|---|---|
| ICH Q10 Pharmaceutical Quality System canonical | 4 |
| ICH Q10 | 1 |
| International Conference on Harmonisation Q10 Pharmaceutical Quality System | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T1151206 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: ICH Q10 Pharmaceutical Quality System Context triple: [International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, notableWork, ICH Q10 Pharmaceutical Quality System]
-
A.
ICH Q8 Pharmaceutical Development
ICH Q8 Pharmaceutical Development is an international guideline that outlines a systematic, science- and risk-based approach to pharmaceutical product and process development, forming a core part of the ICH quality framework.
-
B.
ICH Q9 Quality Risk Management
ICH Q9 Quality Risk Management is an international guideline that provides a systematic, science- and risk-based approach to identifying, evaluating, and controlling quality risks throughout the lifecycle of pharmaceutical products.
-
C.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
-
D.
ISO 13485
ISO 13485 is an international quality management standard that specifies requirements for organizations involved in the design, production, installation, and servicing of medical devices and related services.
-
E.
ISO 14971
ISO 14971 is an international standard that specifies a systematic process for risk management of medical devices throughout their life cycle.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: ICH Q10 Pharmaceutical Quality System Target entity description: ICH Q10 Pharmaceutical Quality System is an international guideline that establishes a comprehensive, lifecycle-based framework for pharmaceutical quality management to ensure consistent product quality and regulatory compliance.
-
A.
ICH Q8 Pharmaceutical Development
ICH Q8 Pharmaceutical Development is an international guideline that outlines a systematic, science- and risk-based approach to pharmaceutical product and process development, forming a core part of the ICH quality framework.
-
B.
ICH Q9 Quality Risk Management
ICH Q9 Quality Risk Management is an international guideline that provides a systematic, science- and risk-based approach to identifying, evaluating, and controlling quality risks throughout the lifecycle of pharmaceutical products.
-
C.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
-
D.
ISO 13485
ISO 13485 is an international quality management standard that specifies requirements for organizations involved in the design, production, installation, and servicing of medical devices and related services.
-
E.
ISO 14971
ISO 14971 is an international standard that specifies a systematic process for risk management of medical devices throughout their life cycle.
- F. None of above. chosen
Statements (44)
| Predicate | Object |
|---|---|
| instanceOf |
ICH guideline
ⓘ
international guideline ⓘ pharmaceutical quality guideline ⓘ |
| aimsTo |
enhance pharmaceutical quality
ⓘ
ensure consistent product quality ⓘ facilitate regulatory compliance ⓘ promote continual improvement ⓘ |
| alignedWith |
Good Manufacturing Practice requirements
ⓘ
ICH Q8 Pharmaceutical Development ⓘ ICH Q9 Quality Risk Management ⓘ |
| appliesTo |
pharmaceutical industry
ⓘ
pharmaceutical quality systems ⓘ |
| basedOn |
ICH Q8 Pharmaceutical Development
ⓘ
ICH Q9 Quality Risk Management ⓘ |
| focusesOn |
integration of quality risk management and quality system elements
ⓘ
product lifecycle management ⓘ |
| fullName |
ICH Q10 Pharmaceutical Quality System
self-linksurface differs
ⓘ
surface form:
International Conference on Harmonisation Q10 Pharmaceutical Quality System
|
| hasAbbreviation |
ICH Q10 Pharmaceutical Quality System
self-linksurface differs
ⓘ
surface form:
ICH Q10
|
| hasConcept |
change management system
ⓘ
continual improvement of the quality system ⓘ corrective and preventive action system ⓘ lifecycle approach to pharmaceutical products ⓘ management responsibility ⓘ management review of process performance and product quality ⓘ pharmaceutical quality system model ⓘ process performance and product quality monitoring system ⓘ |
| hasScope |
commercial manufacturing
ⓘ
pharmaceutical development ⓘ product discontinuation ⓘ technology transfer ⓘ |
| intendedForUseBy |
pharmaceutical manufacturers
ⓘ
regulatory authorities ⓘ |
| issuedBy | International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use ⓘ |
| objective |
achieve product realization
ⓘ
establish and maintain a state of control ⓘ facilitate continual improvement throughout the product lifecycle ⓘ |
| promotes |
quality risk management
ⓘ
science- and risk-based pharmaceutical development ⓘ |
| providesFrameworkFor |
pharmaceutical quality management
ⓘ
regulatory flexibility based on product and process understanding ⓘ |
| supports |
ICH Q8 Pharmaceutical Development
ⓘ
ICH Q9 Quality Risk Management ⓘ effective pharmaceutical quality system implementation ⓘ knowledge management in pharmaceutical organizations ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: ICH Q10 Pharmaceutical Quality System Description of subject: ICH Q10 Pharmaceutical Quality System is an international guideline that establishes a comprehensive, lifecycle-based framework for pharmaceutical quality management to ensure consistent product quality and regulatory compliance.
Referenced by (6)
Full triples — surface form annotated when it differs from this entity's canonical label.